Japan OKs world's first iPS stemcell clinical trial

Jun 27, 2013 by Kyoko Hasegawa

Japan has given the green light to the world's first clinical trial using stem cells harvested from a patient's own body, officials said Thursday, testing a treatment that may offer hope to millions of people robbed of their sight.

A government committee approved proposals for tests aimed at treating age-related macular degeneration (AMD), a common medical condition that causes blindness in older people, using "induced Pluripotent Stem (iPS) cells", a health ministry official said.

The trial treatment will try to create retinal cells that can be transplanted into the eyes of patients suffering from AMD, replacing the damaged part of the eye.

AMD, a condition that is incurable at present, affects mostly middle-aged and older people and can lead to blindness. It afflicts around 700,000 people in Japan alone.

Stem cell research is a pioneering field that has excited many in the scientific community with the potential they believe it offers.

A China-based research group on Wednesday said they were hoping for regulatory approval to test stemcell therapy on spinal cord injuries they believe can help immobile people walk again.

Stem cells are infant cells that can develop into any part of the body.

Until the discovery of iPS cells several years ago, the only way to obtain stem cells was to harvest them from human embryos.

This is controversial because it requires the destruction of the embryo, a process to which religious conservatives, among others, object.

Groundbreaking work done in 2006 by Shinya Yamanaka at Kyoto University, a Nobel Laureate in medicine last year, succeeded in generating stem cells from adult skin tissue.

Like embryonic stem cells, iPS cells are also capable of developing into any cell in the body, but crucially their source material is readily available.

Following the government approval, the Riken Center for Developmental Biology will start the world's first clinical trial using iPS cells as soon as next summer, a Riken spokesman said.

Riken will recruit six patients suffering from AMD, all aged at least 50 years, and take cells from their skin.

These cells will be genetically reprogrammed to become iPS cells. The infant cells will then be nudged in the direction of developing into retina cells.

Once a network of retina cells has been developed—a process that could take around 10 months—this can be transplanted into the patient's eye, the spokesman said.

Patients will be monitored over the next four years to determine how well the implants have performed, whether the body has accepted them and if they have become cancerous.

"Because no one in the world has used iPS cells in a clinical trial, what we are doing will set the standard," research leader Masayo Takahashi told the Mainichi, a daily paper. "It's a daunting prospect, but one that brings joy."

She said she expects that patients in the initial trial will see only a very modest improvement in their sight.

"We don't want people to have excessive expectations," she said.

Kanji Takahashi, chief ophthalmologist at Kansai Medical University Hirokata hospital, told AFP the trial was a positive step, but not a done deal.

He said current treatment regimes include monthly drug injections directly into the eyes of AMD sufferers, at a cost of 150,000-170,000 yen ($1,500-$1,700) per injection.

"Improving the eyesight of AMD patients is a difficult task, and what's important is whether transplanting cells improves vision," he said.

"The trial is a hope for AMD patients, but it will probably take years before the new treatment will actually contribute to improving the vision of many people."

Explore further: Hot-spring bacteria reveal ability to use far-red light for photosynthesis

add to favorites email to friend print save as pdf

Related Stories

Japan researchers close in on stem cell trial

Feb 14, 2013

Researchers in Japan have moved one step closer to clinical trials using adult stem cells in a therapy they hope will prove a cure for common sight problems, an official said Thursday.

Test to improve stem cell safety

Jun 04, 2013

CSIRO scientists have developed a test to identify unsafe stem cells. It is the first safety test specifically for human induced pluripotent stem cells (iPS) – as published today in the international journal Stem Cells.

Stem cells improve visual function in blind mice

Oct 01, 2012

An experimental treatment for blindness, developed from a patient's skin cells, improved the vision of blind mice in a study conducted by Columbia ophthalmologists and stem cell researchers.

Mapping a route to stem cell therapies

May 20, 2013

Monash University researchers are shedding light on the complex processes that underpin the creation and differentiation of stem cells, bringing closer the promise of 'miracle' therapies.

Recommended for you

Some anti-inflammatory drugs affect more than their targets

12 hours ago

Researchers have discovered that three commonly used nonsteroidal anti-inflammatory drugs, or NSAIDs, alter the activity of enzymes within cell membranes. Their finding suggests that, if taken at higher-than-approved ...

Researchers discover new strategy germs use to invade cells

Aug 20, 2014

The hospital germ Pseudomonas aeruginosa wraps itself into the membrane of human cells: A team led by Dr. Thorsten Eierhoff and Junior Professor Dr. Winfried Römer from the Institute of Biology II, members of the Cluster ...

Progress in the fight against harmful fungi

Aug 20, 2014

A group of researchers at the Max F. Perutz Laboratories has created one of the three world's largest gene libraries for the Candida glabrata yeast, which is harmful to humans. Molecular analysis of the Candida ...

How steroid hormones enable plants to grow

Aug 19, 2014

Plants can adapt extremely quickly to changes in their environment. Hormones, chemical messengers that are activated in direct response to light and temperature stimuli help them achieve this. Plant steroid ...

User comments : 5

Adjust slider to filter visible comments by rank

Display comments: newest first

Sanescience
1 / 5 (7) Jun 27, 2013
So, how are people who are supper paranoid about GMO food going to treat GMO people? Are they going to be afraid of a virus incorporating modified genes and spreading? This isn't quite that yet, but it is coming!
atomsk
3.4 / 5 (5) Jun 27, 2013
So, how are people who are supper paranoid about GMO food going to treat GMO people? Are they going to be afraid of a virus incorporating modified genes and spreading? This isn't quite that yet, but it is coming!

Did you read the article? This has nothing to do with gene manipulation.
Sanescience
2 / 5 (4) Jun 27, 2013
Really, you think modifying the genetics of a cell with viruses or chemical genomic insertions is not genetic modification? All righty then.

Try looking up induced Pluripotent Stem cell techniques.
El_Nose
5 / 5 (1) Jun 27, 2013
calling this a world;s first is a strecth -- in Italy stem cell treatment to revive lost eyesight due to chemical burns has been used for almost two decades -- this is the exact same treatment, but for a different cause.

And no this I would not rule as true genetic modification, as the purpose is to have an end result that is genetically identical to what is already in your body.
Sinister1811
1.8 / 5 (5) Jun 28, 2013
calling this a world;s first is a strecth -- in Italy stem cell treatment to revive lost eyesight due to chemical burns has been used for almost two decades -- this is the exact same treatment, but for a different cause.


Definitely. But they aren't induced pluripotent, apparently they're cord blood cells. Not to mention countries like China, India and Mexico which have been treating people for decades. For some reason, we're so far behind in the west.